by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD
Our featured experts discuss baseline and routine laboratory monitoring for patients on biologic therapies. Additionally, they consider the prospec......READ MORE
Multiple factors are considered in the context of treatment failure in patients with plaque psoriasis. These include the type of therapeutic failur......READ MORE
At this time, the recommendation is that, in most cases, barring contraindication, patients with psoriatic disease should get the first COVID-19 va......READ MORE
Counseling is central to the management of psoriasis. Strategies for successful counseling include spending adequate time with patients, maintainin......READ MORE
by Steven R. Feldman, MD, PhD; Joel M. Gelfand, MD, MSCE; and Alice B. Gottlieb, MD, PhD
Body surface area (BSA) affected by psoriasis is a useful tool; however, treatment success often depends importantly on individual patients and the......READ MORE
Psoriasis is increasingly being recognized as a systemic inflammatory disorder with impacts beyond the skin and joints. Obesity and psoriasis, both......READ MORE
